(Q33503504)

27 July 2017

1 reference

title

Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

27 July 2017

1 reference

1 reference

1 reference

thrombotic thrombocytopenic purpura

1 reference

Musio F

1

1 reference

27 July 2017

Bohen EM

series ordinal

2

1 reference

27 July 2017

Yuan CM

series ordinal

3

1 reference

27 July 2017

Welch PG

series ordinal

4

1 reference

27 July 2017

publication date

1 August 1998

1 reference

Seminars in Arthritis and Rheumatism

27 July 2017

published in

1 reference

27 July 2017

volume

28

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

1-19

1 reference

Thrombotic microangiopathies

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Widespread vasculopathy with hemolytic uremic syndrome, perimyocarditis and cystic pancreatitis in a young woman with mixed connective tissue disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Plasma infusions in thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus--a successful outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Systemic lupus erythematosus complicated by thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: clinical significance of anti-platelet antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Fatal thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus. Relationship to circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Simultaneous presentation of thrombotic thrombocytopenic purpura and systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura preceding systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

A case of thrombocytopoenic thrombotic purpura preceding onset of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

A case of systemic lupus erythematosus developing two years after remission of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombotic thrombocytopenic purpura-like syndrome associated with systemic lupus erythematosus--combined treatment with plasmapheresis and fresh frozen plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

THROMBOTIC THROMBOCYTOPENIC PURPURA AND SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Splenic pathology in thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Renal vascular lesions in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Lupus nephritis. Clinical course as related to morphologic forms and their transitions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod: in-vivo and in-vitro observations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Immune Complexes in Thrombotic Thrombocytopenic Purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Demonstration of immune complexes in thrombotic thrombocytopenic purpura: failure to respond to plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

HUS and TTP: variable expression of a single entity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Multiorgan thrombotic disorders in systemic lupus erythematosus: a common link?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

'Primary', 'secondary' and other variants of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Renal manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Antiphospholipid antibodies--autoantibodies with a difference

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Significance of anti-phospholipid antibodies in patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Platelet activation in patients with thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Warfarin dose management affects INR control.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus: A report of two cases with successful treatment of one.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2898%2980023-1

7 January 2021

10.1016/S0049-0172(98)80023-1

Identifiers

DOI

1 reference

release_dinltohxgngv5d5q6iaxbbnu34

27 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dinltohxgngv5d5q6iaxbbnu34

24 November 2022

mapped directly with Wikidata item

1 reference